Aprea Therapeutics
APRE
#11121
Rank
C$4.66 M
Marketcap
C$0.33
Share price
-53.56%
Change (1 day)
-80.10%
Change (1 year)

EPS for Aprea Therapeutics (APRE)

EPS in 2026 (TTM): C-$1.50

According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.55. In 2025 the company made an earnings per share (EPS) of C-$2.84 an increase over its 2024 EPS that were of C-$3.41.

EPS history for Aprea Therapeutics from 2019 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.50-47.24%
2025C-$2.84-16.81%
2024C-$3.41
2022C-$139.40177.74%
2021C-$50.19-31.1%
2020C-$72.8570.91%
2019C-$42.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amedisys
AMED
C$3.74-341.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
C$2.17-239.81%๐Ÿ‡บ๐Ÿ‡ธ USA